Results 151 to 160 of about 17,529 (206)

Time to initial glycopeptide therapy and 30-day mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. [PDF]

BMC Infect Dis
No TH, Mun SJ.
europepmc   +1 more source

Understanding the burden and impact of methicillin-resistant <i>Staphylococcus aureus</i>: exploring therapeutic options and hospital prevention strategies to improve patient outcome at the University Teaching Hospital of Kigali, Rwanda. [PDF]

Front Public Health
Rutare S, Masaisa F, Nkubana T, Dusabe A, Munyemana JB.   +4 more
europepmc   +1 more source

Periprosthetic joint infection (PJI) due to candida tropicalis following total knee arthroplasty (TKA): A case report. [PDF]

IDCases
Razaviyoun T, Hashemi SJ, Asadolahi A, Sarvestani HK, Mahmoudi S, Rafat Z, Samsami H, Salehi M.   +7 more
europepmc   +1 more source

The safety profile of trimethoprim-sulfamethoxazole regarding concomitant other drugs: a comparative analysis of adverse effects in a tertiary level adult intensive care unit. [PDF]

BMC Infect Dis
Durmuş M, Aydın D, Ustaömer S, Güzel Karahan S, Küçük AO, Pehlivanlar Küçük M.   +5 more
europepmc   +1 more source

Albumin-on-a-chip: binding profiling of circulating human albumin via selective immunocapture and real-time SPR analysis. [PDF]

Sci Rep
Nugnes M, Baldassarre M, Caraceni P, Naldi M, Bartolini M, Bartolini M.   +5 more
europepmc   +1 more source

Teicoplanin.

Indian pediatrics, 2002
openaire   +1 more source

Clinical outcomes of teicoplanin use in the OPAT setting [PDF]

International Journal of Antimicrobial Agents, 2020
Teicoplanin possesses several convenient properties for use in the delivery of outpatient parenteral antimicrobial therapy (OPAT) services. However, its use is not widespread and data on its efficacy in the OPAT setting are limited.
Jonathan Underwood, Stephen Morris-Jones, Sarah Logan   +2 more
exaly   +2 more sources